protein

  • AB SCIEX QTRAP technology assists Yale researchers to engineer a phosphoprotein

    Synthetic biology-based approach successfully re-engineers protein-making mechanisms in bacteria.

    protein | 29 September 2011

  • ProImmune launches protein and peptide microarray platform

    ProImmune Ltd announced that it has launched ProArray Ultra, a protein and peptide array platform which is more sensitive than optimized ECL ELISA. According to the company, the new platform allows analysis of more than 30,000 peptides or proteins at…

    protein | 15 June 2011

  • Multiplex immunoassay platform validates prognostic and predictive protein biomarkers

    Data was presented at the recent American Society of Clinical Oncology's 2011 Genitourinary Cancers Symposium showing multiple protein biomarkers predictive of clinical benefit and prognostic of disease outcome in patients with advanced or metastatic…

    protein | 13 June 2011

  • Millennium highlights new protein homeostasis data in metastatic melanoma

    Millennium: The Takeda Oncology Company reported results from two ongoing phase I studies with investigational therapy MLN4924 in metastatic melanoma and other advanced solid tumors. MLN4924, discovered by Millennium, is a small molecule inhibitor of…

    protein | 07 June 2011

  • Protein biomarker analysis

    The SignaturePLUS system is designed to meet the cost and performance needs of researchers for accurate, reproducible, and reliable multiplex protein biomarker analysis across pre-clinical, clinical and diagnostics applications in all therapeutic ar…

    protein | 01 May 2011

  • Evitria achieves 1 gram per liter in rapid protein production

    evitria SA has achieved a breakthrough in transient gene expression. Using Life Technologies’ Invitrogen FreeStyle CHO-S Cells, evitria scientists succeeded in obtaining titers exceeding 1 gram per liter in transient. evitria’s rapid protein…

    protein | 02 March 2011

  • Oncology drives therapeutic protein growth

    Driven primarily by strong demand for engineered antibodies for treating a growing list of cancers, commercial protein drugs – a group that includes recombinant mAbs, cytokines and related immune modulators, growth factors, enzymes, and hormones â…

    protein | 01 January 2011

  • Easy and reliable transmembrane protein characterization

    The Universite de Provence and Universite de la Mediterranee in Marseille, France, have implemented the innovative Wyatt Multi-Angle Light Scattering (MALS) detectors for use in their biological macromolecules joint research unit. The instruments…

    protein | 30 December 2010

  • Addressing multiple disease targets with single protein therapy

    Selexis entered into strategic agreement with Zyngenia under which Selexis will utilize its' SURE cell line development platform to generate production cell lines for Zyngenia’s lead Zybody therapeutic programs. ”We are excited to support Zy…

    protein | 03 December 2010

  • Advancing the study of epigenetic proteins

    Domainex is collaborating with Sigma-Aldrich to provide essential tools, including biochemical assays and monoclonal antibodies, for the study of proteins involved in the rapidly developing field of epigenetics. These epigenetic proteins regulat…

    protein | 27 November 2010

Page 1 Next > Last >>